How does the dosing frequency for NuvaRing compare to other options?

There are so many birth control methods available today that choosing the one that’s right for you can be difficult. The chart below helps you compare the dosing frequency of NuvaRing to some other forms of birth control so you can assess your options and have an informed discussion with your health care provider.

Method Dosing Frequency
Start Over
NuvaRing Monthly*
Combined hormonal pill Daily
Progestin-only pill (Mini-Pill) Daily
Patch Weekly
Progestin-only injection Every 3 months
Diaphragm with spermicide Only when you have sex
Cervical cap with spermicide Only when you have sex
Male condom Only when you have sex
Female condom Only when you have sex
Copper intrauterine device (IUD) Every 10 years
Progestin-only intrauterine device (IUD) Every 3 or 5 years

*In a given 4-week cycle, NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) must be inserted into your vagina, removed after 3 weeks, and a new ring must be inserted 7 days later.


NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) is a flexible birth control vaginal ring used to prevent pregnancy. Available by prescription only.
IMPORTANT SAFETY INFORMATION

Do not use NuvaRing (etonogestrel/ethinyl estradiol vaginal ring) if you smoke cigarettes and are over age 35. Smoking increases your risk of serious heart and blood vessel problems from combination hormonal contraceptives (CHCs) including heart attack, blood clots, or stroke which can be fatal. This risk increases with age and the number of cigarettes smoked.

  • The use of a CHC, like NuvaRing, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions or any condition that makes your blood more likely to clot. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for a month or more.
  • NuvaRing is also not for women with high blood pressure that medicine can't control; diabetes with kidney, eye, nerve, or blood vessel damage; certain kinds of severe migraine headaches; liver disease or liver tumors; unexplained vaginal bleeding; breast cancer or any cancer that is sensitive to female hormones; or if you are or may be pregnant.
  • NuvaRing does not protect against HIV infection (AIDS) and other sexually transmitted infections.
  • The most common side effects reported by users of NuvaRing are irritation inside your vagina or on your cervix; headache (including migraine); mood changes (including depression); the ring slipping out or causing discomfort; nausea and vomiting; vaginal discharge; weight gain; vaginal discomfort; breast pain, discomfort, or tenderness; painful menstrual periods; abdominal pain; acne; and less sexual desire.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your health care provider. The physician Prescribing Information is also available.